Fibrinogen-to-Albumin Ratio as a Predictor of Acute Respiratory Distress Syndrome in Traumatic Brain Injury

Recruiting now

Conditions studied: Fibrinogen, Albumin, ARDS, TBI (Traumatic Brain Injury)

In brief

this study aims to assess the ability of fibrinogen-to-albumin ratio to predict the development of Acute respiratory distress syndrome in traumatic brain injury patients.

Key facts

Study ID

NCT07664358

Run by

Tanta University

People needed

350

Starts

2026-07-01

Expected to finish

2027-01-01

Last updated by the study team

2026-07-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients ≥ 18 years admitted to the ICU with traumatic Brain Injury
• Admission to the ICU within 24 hours of injury.
• Patients will be expected to remain under hospital care for follow-up
• Availability of fibrinogen and albumin measurements within the first 24 hours of ICU admission.
• Informed consent will be obtained from a legally authorized representative.

You may not qualify if…

• Preexisting advanced chronic liver disease, nephrotic syndrome, or protein-losing enteropathy.
• Pre-existing ARDS on admission.
• Recipient of albumin, fibrinogen concentrate, or cryoprecipitate before admission sampling.
• Use of anticoagulant or fibrinolytic therapy before admission.
• Active malignancy or severe systemic infection at admission.
• Direct sever lung injury
• Pregnancy
• Refusal of consent

Where it is running

• Tanta University Hospitals — Tanta, Gharbia Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.